DOT Memo: Schedule III Move Doesn't Change Drug Testing for Drivers

The U.S. Department of Transportation issued a memo clarifying that marijuana's rescheduling to Schedule III has zero impact on drug testing requirements for safety-sensitive transportation workers—including truck drivers, pilots, and bus operators.

The memo closes a loophole some workers hoped would emerge after the Drug Enforcement Administration's historic rescheduling decision earlier this year. Medical marijuana cards, physician recommendations, and dispensary receipts remain irrelevant under DOT testing protocols.

"This is creating a real workforce challenge," said Paul Armentano, deputy director of NORML. The transportation industry already faces a driver shortage exceeding 80,000 positions, according to American Trucking Associations data. Yet federal regulations continue to disqualify workers who use cannabis off-duty in states where it's legal.

The Testing Standards

DOT regulations mandate drug testing for approximately 12 million workers in aviation, trucking, rail, maritime, transit, and pipeline industries. The standards haven't changed since their implementation in the 1990s, when marijuana was firmly Schedule I.

Workers in these positions face pre-employment screening, random testing, post-accident testing, and reasonable suspicion testing. A positive result for THC metabolites—which can appear weeks after use—triggers immediate removal from safety-sensitive duties.

The memo specifically addresses state medical marijuana programs. Even workers with valid medical cards in the 38 states that have legalized medical cannabis cannot use marijuana without violating federal transportation safety rules. The DOT maintains that impairment risk in safety-sensitive positions overrides state-level medical authorizations.

Industry Impact

The policy disconnect creates particular challenges in states like California, where recreational cannabis is legal and the trucking industry struggles to fill positions. Some companies report rejecting 50% or more of applicants due to failed drug tests, with marijuana accounting for the majority of positive results.

But the DOT draws a hard line. Unlike alcohol—which transportation workers can consume off-duty as long as they're not impaired on the job—marijuana use remains completely prohibited. The department cites concerns about detecting active impairment, given that current testing methods identify past use rather than real-time intoxication.

"We're still using 1980s technology to test for a substance that half the country has legalized," noted Kevin Sabet, president of Smart Approaches to Marijuana, who nonetheless supports maintaining strict standards for safety-sensitive positions.

What Schedule III Actually Changed

The rescheduling decision, finalized by the DEA in May, primarily affects research access and tax treatment for cannabis businesses. Schedule III drugs—which include ketamine and anabolic steroids—are recognized as having medical value and lower abuse potential than Schedule I substances.

For cannabis businesses, the move enables them to claim standard business deductions under Section 280E of the tax code. For researchers, it theoretically eases access to cannabis for clinical studies.

What it didn't change: workplace drug policies, federal employment restrictions, or transportation safety regulations.

The Path Forward

Some lawmakers have proposed legislation to address the testing gap. Rep. Earl Blumenauer's bill would require DOT to develop impairment-based testing standards within two years. But the legislation has stalled in committee.

Meanwhile, the transportation industry continues operating under a patchwork system where workers can legally purchase cannabis in their home state but face career-ending consequences for using it. The DOT has indicated no plans to revise its drug testing protocols unless Congress mandates changes or reliable impairment testing technology emerges.

For now, the estimated 12 million workers in safety-sensitive transportation positions face a clear choice: cannabis or career. The Schedule III reclassification changed nothing about that calculation.

---

This article is based on original reporting by hightimes.com.